The global dyslipidemia treatment market is experiencing significant expansion in the coming years. This trend can be attributed to a growing prevalence of cardiovascular diseases, coupled with aging populations. The market is heavily influenced by key players who are regularly developing novel treatment options. Key segments within the dyslipidem